200 related articles for article (PubMed ID: 28384095)
1. Age-Specific Indicators of a Healthy Lifestyle and Postmenopausal Breast Cancer.
McClain KM; McCullough LE; Bradshaw PT; Shantakumar S; Terry MB; Neugut AI; Gammon MD
J Womens Health (Larchmt); 2017 Nov; 26(11):1176-1184. PubMed ID: 28384095
[TBL] [Abstract][Full Text] [Related]
2. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
[TBL] [Abstract][Full Text] [Related]
3. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
[TBL] [Abstract][Full Text] [Related]
4. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR
Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045
[TBL] [Abstract][Full Text] [Related]
5. Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk.
Cui Y; Deming-Halverson SL; Beeghly-Fadiel A; Lipworth L; Shrubsole MJ; Fair AM; Shu XO; Zheng W
Clin Cancer Res; 2014 Mar; 20(5):1169-78. PubMed ID: 24423614
[TBL] [Abstract][Full Text] [Related]
6. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
[TBL] [Abstract][Full Text] [Related]
7. Influence of lifestyle factors on mammographic density in postmenopausal women.
Brand JS; Czene K; Eriksson L; Trinh T; Bhoo-Pathy N; Hall P; Celebioglu F
PLoS One; 2013; 8(12):e81876. PubMed ID: 24349146
[TBL] [Abstract][Full Text] [Related]
8. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
[TBL] [Abstract][Full Text] [Related]
9. Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study.
Han D; Nie J; Bonner MR; McCann SE; Muti P; Trevisan M; Ramirez-Marrero FA; Vito D; Freudenheim JL
Int J Cancer; 2006 Dec; 119(12):2931-7. PubMed ID: 17016824
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
11. Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity.
McCullough LE; Chen J; White AJ; Xu X; Cho YH; Bradshaw PT; Eng SM; Teitelbaum SL; Terry MB; Garbowski G; Neugut AI; Hibshoosh H; Santella RM; Gammon MD
Int J Cancer Clin Res; 2015; 2(1):. PubMed ID: 26005715
[TBL] [Abstract][Full Text] [Related]
12. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.
Ma H; Ursin G; Xu X; Lee E; Togawa K; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Lu Y; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2018 Jan; 20(1):5. PubMed ID: 29357906
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women.
Cerne JZ; Ferk P; Leskosek B; Gersak K
Climacteric; 2011 Aug; 14(4):458-63. PubMed ID: 21294673
[TBL] [Abstract][Full Text] [Related]
14. Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.
Tamimi RM; Spiegelman D; Smith-Warner SA; Wang M; Pazaris M; Willett WC; Eliassen AH; Hunter DJ
Am J Epidemiol; 2016 Dec; 184(12):884-893. PubMed ID: 27923781
[TBL] [Abstract][Full Text] [Related]
15. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.
Barnes BB; Steindorf K; Hein R; Flesch-Janys D; Chang-Claude J
Cancer Epidemiol; 2011 Aug; 35(4):345-52. PubMed ID: 21159569
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer risk: effects of estrogen replacement therapy and body mass.
Harris RE; Namboodiri KK; Wynder EL
J Natl Cancer Inst; 1992 Oct; 84(20):1575-82. PubMed ID: 1404451
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.
Chen Y; Gammon MD; Teitelbaum SL; Britton JA; Terry MB; Shantakumar S; Eng SM; Wang Q; Gurvich I; Neugut AI; Santella RM; Ahsan H
Carcinogenesis; 2008 Apr; 29(4):766-71. PubMed ID: 18281250
[TBL] [Abstract][Full Text] [Related]
18. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Incidence and Mortality in Relation to Hormone Replacement Therapy Use Among Postmenopausal Women: Results From a Prospective Cohort Study.
Jiang Y; Xie Q; Chen R
Clin Breast Cancer; 2022 Feb; 22(2):e206-e213. PubMed ID: 34548240
[TBL] [Abstract][Full Text] [Related]
20. Physical activity and the risk of postmenopausal breast cancer - the Norwegian Women and Cancer Study.
Borch KB; Lund E; Braaten T; Weiderpass E
J Negat Results Biomed; 2014 Mar; 13():3. PubMed ID: 24580799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
